Maternal Serum Alpha-fetoprotein Levels in Fetal Hydrocephalus
July 7th 2006Although maternal serum alpha-fetoprotein (MSAFP) is a highly sensitive marker for certain congenital malformations such as open neural tube and ventral wall defects, its usefulness as a screening test for fetal hydrocephalus is uncertain.
WHO systematic review of prevalence of CPP: a neglected reproductive health morbidity
July 6th 2006Health care planning for chronic pelvic pain (CPP), an important cause of morbidity amongst women is hampered due to lack of clear collated summaries of its basic epidemiological data. We systematically reviewed worldwide literature on the prevalence of different types of CPP to assess the geographical distribution of data, and to explore sources of variation in its estimates.
Antioxidant supplementation during pregnancy: Harmful rather than helpful?
July 1st 2006Supplementation with the antioxidant vitamins C and E during pregnancy doesn't reduce the risks of preeclampsia, intrauterine growth restriction, infant death, or other serious infant outcomes in nulliparous women, according to the results of a recent multicenter, randomized trial. In fact, women taking the vitamins may be more likely to develop hypertension and to require treatment with antihypertensive drugs.
Bar-coding is not a panacea for halting patient mix-ups
July 1st 2006At least that's what Clement J. McDonald, MD, emphasized in an article in the Annals of Internal Medicine (4/4/06). Presenting an actual case, in which two patients were misidentified when a mix-up occurred with their bar-coded identification wristbands, McDonald drew several conclusions to improve risk management
Breast Ca overdiagnosed in 1 in 10 middle-aged women
July 1st 2006About 1 in 10 women between the ages of 55 and 69 who is diagnosed with breast cancer is diagnosed unnecessarily because her disease would never have come to clinical attention if she were not screened. The findings come 15 years after the end of the population-based Swedish Malm? mammographic screening trial, a randomized, controlled trial of over 40,000 women.
C-section important risk factor for placenta previa/abruption
July 1st 2006A cesarean first birth increases the risks for placenta previa and placenta abruption in subsequent pregnancies. So does a short interpregnancy interval, according to a retrospective cohort study of almost 200,000 singleton pregnancies.
Explaining ovulation awareness-based family planning methods
July 1st 2006These easily taught birth control methods may be just what some patients are looking for. Nonhormonal approaches like the Standard Days and the TwoDay Methods hinge on identifying a woman's fertile window: the days during her cycle when pregnancy is likely.
Grand Rounds: Hysterectomy sans oophorectomy: The case for leaving a woman's ovaries alone
July 1st 2006If there's no cancer present, why remove a woman's ovaries during hysterectomy? Does the reduced risk of ovarian cancer outweigh the consequences of eliminating the protective hormones secreted by a healthy pair of ovaries? A team of researchers offers some thought-provoking conclusions.
New Studies Examine Treatments, Causes and Risks for Women with PCOS
June 22nd 2006New research presented today on treatments, causes and risks associated with Polycistic Ovary Syndrome (PCOS), a disease that effects between five and 10 percent of reproductive aged women, offers a glimmer of hope to the millions of women who suffer from the painful and debilitating disease.
Prescribing Patterns in Premenstrual Syndrome
June 20th 2006Over 300 therapies have been proposed for premenstrual syndrome. To date there has been only one survey conducted in the UK of PMS treatments prescribed by GPs, a questionnaire-based study by the National Association of Premenstrual Syndrome in 1989.
Using aromatase inhibitors to stimulate a woman's ovaries
June 1st 2006Although clomiphene citrate and FSH remain the mainstay of therapy for ovarian stimulation among women with unexplained infertility, both drugs have their shortcomings. Two experts present the evidence supporting the value of AIs in this patient population.
Demystifying combined HPV-Pap screening guidelines, Part 2
June 1st 2006A leading expert helps you educate yourself-and your patients-about putting combined HPV-Pap testing into practice. Patient education should stress how common HPV is and explain the high level of reassurance testing negative on both tests affords.